SCHEMBL6163614

SCHEMBL6163614

COC(=O)COc1ccc(-c2ccccc2)cc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.69
NPC1 O15118 3/20 0.64
SMN1; SMN2 Q16637 3/20 0.64
RAB9A P51151 2/20 0.64
LMNA P02545 3/20 0.62
CASP3 P42574 1/20 0.62
SENP8 Q96LD8 1/20 0.62
SENP7 Q9BQF6 1/20 0.62
SENP6 Q9GZR1 1/20 0.62
FAAH O00519 1/20 0.59
ALDH1A1 P00352 4/20 0.58
KMT2A Q03164 3/20 0.58
POLB P06746 2/20 0.58
MEN1 O00255 2/20 0.58
KDM4E B2RXH2 2/20 0.58
CTDSP1 Q9GZU7 1/20 0.58
L3MBTL1 Q9Y468 1/20 0.58
MAPK1 P28482 1/20 0.56
PTGS2 P35354 1/20 0.54
HDAC3 O15379 3/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13918253 0.91 FFAR1 (0.61) MAPTNPC1SMN1; SMN2RAB9ALMNA
SCHEMBL544051 0.89 ALOX15 (0.63) MAPTNPC1SMN1; SMN2RAB9AFAAH
Benzene SCHEMBL28258789 0.89 ALOX15 (0.63) MAPTNPC1SMN1; SMN2RAB9AFAAH
Hydrochloric Acid SCHEMBL1959413 0.87 ALOX15 (0.61) MAPTNPC1SMN1; SMN2RAB9AFAAH
SCHEMBL28313123 0.87 ALOX15 (0.61) MAPTNPC1SMN1; SMN2RAB9AFAAH
SCHEMBL2116437 0.87 PTGS2 (0.66) MAPTSMN1; SMN2LMNAALDH1A1KMT2A
SCHEMBL15145781 0.86 SMN1; SMN2 (0.63) MAPTSMN1; SMN2RAB9AFAAHKMT2A
SCHEMBL20392616 0.85 MAPT (0.52) MAPTNPC1SMN1; SMN2RAB9ALMNA
SCHEMBL3973631 0.84 PTGS2 (0.53) MAPTNPC1SMN1; SMN2RAB9ALMNA
Hydrochloric Acid SCHEMBL3973727 0.83 PTGS2 (0.51) MAPTNPC1SMN1; SMN2RAB9ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1379516-B1 ALKOXYCARBONYLAMINO BENZOIC ACID OR ALKOXYCARBONYLAMINO TETRAZOLYL PHENYL DERIVATIVES AS IP ANTAGONISTS HOFFMANN LA ROCHE (CH) 2005-11-16 EP disclosed
US-6903086-B2 Alkoxycarbonylamino benzoic acid or alkoxycarbonylamino tetrazolyl phenyl derivatives as IP antagonists SYNTEX (U.S.A.) LLC (US) 2005-06-07 US disclosed
EP-1379516-A1 ALKOXYCARBONYLAMINO BENZOIC ACID OR ALKOXYCARBONYLAMINO TETRAZOLYL PHENYL DERIVATIVES AS IP ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2004-01-14 EP disclosed
US-20020165235-A1 Alkoxycarbonylamino benzoic acid or alkoxycarbonylamino tetrazolyl phenyl derivatives as IP antagonists SYNTEX (U.S.A.) LLC 2002-11-07 US disclosed
WO-2002070500-A1 ALKOXYCARBONYLAMINO BENZOIC ACID OR ALKOXYCARBONYLAMINO TETRAZOLYL PHENYL DERIVATIVES AS IP ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2002-09-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020165235-A1 Alkoxycarbonylamino benzoic acid or alkoxycarbonylamino tetrazolyl phenyl derivatives as IP antagonists GPBAR1, GABRP, TBXA2R MAPT 4798/4885NPC1 906/4885SMN1; SMN2 3978/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.